PL2114921T3 - Podstawiona pochodna oksindolu i jej zastosowanie jako liganda receptora wazopresyny - Google Patents

Podstawiona pochodna oksindolu i jej zastosowanie jako liganda receptora wazopresyny

Info

Publication number
PL2114921T3
PL2114921T3 PL07858212T PL07858212T PL2114921T3 PL 2114921 T3 PL2114921 T3 PL 2114921T3 PL 07858212 T PL07858212 T PL 07858212T PL 07858212 T PL07858212 T PL 07858212T PL 2114921 T3 PL2114921 T3 PL 2114921T3
Authority
PL
Poland
Prior art keywords
receptor ligand
vasopressin receptor
oxindole derivative
substituted oxindole
substituted
Prior art date
Application number
PL07858212T
Other languages
English (en)
Inventor
Astrid Netz
Thorsten Oost
Hervé Geneste
Wilfried Martin Braje
Wolfgang Wernet
Liliane Unger
Wilfried Hornberger
Wilfried Lubisch
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of PL2114921T3 publication Critical patent/PL2114921T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL07858212T 2006-12-30 2007-12-28 Podstawiona pochodna oksindolu i jej zastosowanie jako liganda receptora wazopresyny PL2114921T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006062508 2006-12-30
PCT/EP2007/064619 WO2008080970A1 (en) 2006-12-30 2007-12-28 Substituted oxindole derivative and its use as a vasopressin receptor ligand
EP07858212A EP2114921B1 (en) 2006-12-30 2007-12-28 Substituted oxindole derivative and its use as a vasopressin receptor ligand

Publications (1)

Publication Number Publication Date
PL2114921T3 true PL2114921T3 (pl) 2013-05-31

Family

ID=39140670

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07858212T PL2114921T3 (pl) 2006-12-30 2007-12-28 Podstawiona pochodna oksindolu i jej zastosowanie jako liganda receptora wazopresyny

Country Status (9)

Country Link
EP (1) EP2114921B1 (pl)
CY (1) CY1114543T1 (pl)
DK (1) DK2114921T3 (pl)
ES (1) ES2401908T3 (pl)
PL (1) PL2114921T3 (pl)
PT (1) PT2114921E (pl)
RS (1) RS52700B (pl)
SI (1) SI2114921T1 (pl)
WO (1) WO2008080970A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
UY30846A1 (es) 2006-12-30 2008-07-31 Abbott Gmbh & Amp Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
US8703775B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
CA2707669C (en) * 2007-12-07 2016-07-05 Wilfried Braje 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2009071691A2 (de) * 2007-12-07 2009-06-11 Abbott Gmbh & Co. Kg Oxindol-derivate und ihre verwendung als medikament
CA2707671C (en) 2007-12-07 2016-02-02 Abbott Gmbh & Co. Kg 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
US8703774B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
EP2435080A2 (en) 2009-05-29 2012-04-04 Abbott Laboratories Pharmaceutical compositions for the treatment of pain
CN102573836A (zh) * 2009-06-10 2012-07-11 雅培股份有限两合公司 取代的羟吲哚衍生物治疗和预防疼痛的应用
CN103380127B (zh) 2010-12-21 2016-08-10 拜耳知识产权有限责任公司 制备n-磺酰基取代的羟吲哚的方法
CA2903141A1 (en) 2013-03-14 2014-09-18 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases
AR095327A1 (es) 2013-03-14 2015-10-07 Abbvie Deutschland Derivados oxindol con un sustituyente oxetano y uso de los mismos para tratar enfermedades relacionadas con la vasopresina
US9862704B2 (en) 2013-12-20 2018-01-09 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
WO2015091931A1 (en) 2013-12-20 2015-06-25 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
US9527856B2 (en) 2014-05-15 2016-12-27 AbbVie Deutschland GmbH & Co. KG Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
EP3371170B1 (en) 2015-11-06 2019-07-31 H. Hoffnabb-La Roche Ag Indolin-2-one derivatives useful in the treatment of cns diseases
PH12018500978B1 (en) 2015-11-06 2023-05-05 Hoffmann La Roche Indolin-2-one derivatives
CN108137561B (zh) 2015-11-06 2021-03-26 豪夫迈·罗氏有限公司 二氢吲哚-2-酮衍生物
WO2017076931A1 (en) 2015-11-06 2017-05-11 F. Hoffmann-La Roche Ag Indolin-2-one derivatives for use in the treatment of cns and related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070718A1 (en) * 2003-09-30 2005-03-31 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
DE102004033834A1 (de) * 2004-07-13 2006-02-02 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate und diese enthaltende Arzneimittel
CA2602194A1 (en) * 2005-03-24 2006-09-28 Abbott Gmbh & Co. Kg Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
DE102005014904A1 (de) * 2005-03-26 2007-02-01 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung

Also Published As

Publication number Publication date
EP2114921A1 (en) 2009-11-11
DK2114921T3 (da) 2013-03-25
PT2114921E (pt) 2013-03-26
ES2401908T3 (es) 2013-04-25
HK1132741A1 (en) 2010-03-05
WO2008080970A1 (en) 2008-07-10
SI2114921T1 (sl) 2013-05-31
RS52700B (sr) 2013-08-30
EP2114921B1 (en) 2012-12-26
CY1114543T1 (el) 2016-10-05

Similar Documents

Publication Publication Date Title
PT2114921E (pt) Derivado de oxindol substituído e sua utilização como ligante do recetor de vasopressina
ZA200904363B (en) Substituted oxindole derivatives and their use as vasopressin receptor ligands
EP2049520A4 (en) indole compounds
ZA200902585B (en) Indole compound
IL188039A0 (en) Oxindole derivatives
PL2017278T3 (pl) Pochodne dihydropirazolopirymidynonu
EP2009005A4 (en) AZOLECARBOXAMIDE DERIVATIVE
IL194391A0 (en) 5-amido-2-carboxamide indoles
IL180020A0 (en) Encryption -and decryption-enabled interfaces
EP1955697A4 (en) 2-AMINOBENZAMIDE DERIVATIVE
IL199430A0 (en) Crth2 antagonists
IL192270A0 (en) Substituted oxadiazole derivatives and their use as opioid receptor ligands
EP2131656A4 (en) phthalazine
ZA200905265B (en) Indole derivatives
ZA200904479B (en) Nitroderivatives as angiotensin II receptor antagonists
ZA200900843B (en) Indole compounds
IL198633A0 (en) Indoles
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
GB201000798D0 (en) Poly-TLR antagonists
PL1918639T3 (pl) Podzespół palnika
EP1975162A4 (en) oxazolone derivatives
EP2130829A4 (en) NEW HYDROXYINDOLE DERIVATIVE
GB2438967B (en) Hopper unit
GB0603404D0 (en) Materials screen
GB0621406D0 (en) Kirby